Author of the article: Reuters . And less than a month ago, Centene said Neidorff was taking a medical leave of absence to address what he called a treatable medical condition, putting several executives including London to work to fill the void left by Neidorffs absence. Nov 2013 - Mar 20173 years 5 months. FORTUNE magazine continuously ranks us as one of America's fastest-growing companies. Centene Corporation, (d) Election of Sarah London as a Member of the Board, ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL In announcing the 41-year-old Londons elevation to Centenes top job, the company described her as at the forefront of innovation in healthcare . London succeeds Michael Neidorff, who went on medical leave late last month, the company said. London, who has been vice chairman of Centenes board, has led the companys technology and digital strategy while also running the health insurers health care enterprises and specialty divisions, corporate strategy, quality operations, internal audit, compliance and risk management, the company said. Brent Layton, President and Chief Operating Officer of Centene, stated, "Sarah brings a tremendous skillset to the leadership of Centene Corporation, and I'm excited to partner closely with her as Centene begins our journey into the next era of our history. The salaries that employees earn in Centene can be influenced by the department or organization function that they work in. Sarah London Work Experience and Education. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. Biography. Sarah London | 2022 Most Powerful Women. Chief Executive Officer. Share Your Design Ideas, New JerseysMurphy Defends $10 Billion Rainy Day Fund as States Economy Slows, This Week in Crypto: Ukraine War, Marathon Digital, FTX. Share & Print. Drew Asher. Neidorff remains on a previously announced medical leave of absence from his position on the board of the company. Since then, the company has become a major force in the commercial health insurance market by acquiring Health Net, a California health insurer; WellCare Health Plans, a big Medicare plans issuer; and Magellan Health, a behavioral health, specialty care and pharmacy benefits manager. Insiders trading at Centene Over the last 19 years, insiders at Centene have traded over $220,031,916 worth of Centene stock and bought 89,005 units worth $5,026,837 . Create an alert to follow a developing story, keep current on a competitor, or monitor industry news. As Centenes first woman CEO, London has been instrumental in helping the insurer boost earnings and grow its core lines of business. I write about healthcare business and policy. --------------------------------------------------------------------------------. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. Sarah's mailing address filed with the SEC is 7700, Forsyth Boulevard, Clayton, Saint Louis County, Missouri, 63105, United States . New SEC Custody Rule Would Scare Away Qualified Custodians: Lawyer, Why Secure 2.0s RMD Delay Matters Even More Than Many Think, Long COVID Correlates With High Mortality: Health Insurer, Antitrust Suit Challenging Schwab-TD Ameritrade Deal Can Proceed, Judge Rules, When Medicare Enrollees Return to Work: A Medicare Customer Q&A, How to Attract the Best, Most Overlooked Clients, Divorce Looks Like Forced Early Retirement for Many Wealthy Women, Advisor Says, Advisor Speaks Out on Industry's Treatment of Women. "The healthcare landscape is rapidly changing, and Centene's mission to transform the health of our communities one member at a time has never been more relevant. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. London started at Optum as the chief product officer at Optum Analytics. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. CENTENE CORP income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. MH magazine offers content that sheds light on healthcare leaders complex choices and touch pointsfrom strategy, governance, leadership development and finance to operations, clinical care, and marketing. Dec 5, 2022. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company. The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings. California Weighs $360,000 in Reparations to Eligible Black Residents. Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. This morning we reported second quarter revenues at $27.7 billion, an increase of 51% over the second quarter of 2019. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Biography. And adjusted. ", Drew Asher, Centene's Chief Financial Officer, said, "Sarah brings a modern vision to the helm of one of this country's most important healthcare companies. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). The oldest executive at Centene Corp. is RobertDitmore, 86, who is the Presiding Independent Director. Since Mr. Neidorff began a medical leave of absence in February 2022, she has been a member of the Office of the Chairman charged with running the day-to-day management of the Company. Centene Salaries trends. Centenes large size and central role in behavioral care management mean that it could affect what retirement planning clients Medicare plans look like, what the plans will cost, and how both working-age and older clients plans cover mental health care, behavioral health care and other types of care. She graduated from the school with a bachelors degree in literature in 2002. London has been a Centene executive since 2020. In a March 31 regulatory filing, Centene said its board of directors had approved a compensation package for new CEO Sarah London with an annual base salary of $1.4 million and a cash. Executive Compensation Data Year: Trend Analysis As at CENTENE CORP, made $0 in total compensation. Copyright 2023 Surperformance. I'm excited by the tremendous opportunity to leverage the size and scale of this Company to create true, sustaining value for our members, state partners, employees and shareholders.". These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. Chief Operating Officer. She later earnedan MBA from the University of Chicago. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company. ESG: The Implementation Imperative Summit. 5.0 . Mar. Women represent 76% of our employees and 65% of employees in supervisory positions. The most active insiders traders include Michael F Neidorff, Frederick H Eppinger, and Edward L Cahill. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. Centene Centene has promoted Sarah London, the health insurance company's current board vice chair, to the job as Chief Executive Officer, succeeding the retiring Michael Neidorff, the. While at Optum Ventures, she oversaw investments in companies such as IDx, a startup that uses artificial intelligence to detect diabetic retinopathy, and Apervita, a health care quality data company. Ms. London previously served as the Company's Senior Vice President of Technology Innovation and Modernization, responsible for enterprise-wide technology strategy and execution with a focus on next-generation products and services. March 22 (Reuters) - U.S. health insurer Centene Corp CNC.N on Tuesday named Vice Chairman Sarah London as its new chief executive officer, replacing Michael Neidorff, who is on medical leave. Net income dropped 26% to $1.3 billion. To no one's great surprise, the pick is Sarah London, formerly vice chair of the Centene board of directors, one-third of their 'value creation office', and part of the Office of the . The most recent stock trade was executed by Andrew Lynn Asher on 9 February 2023, trading 6,800 units of CNC stock currently worth $489,124. But how CEO Sarah London decides to move the company. Sarah London, vice chairman of the board of directors at Centene (NYSE: CNC), has accepted additional responsibilities as CEO of the St. Louis-based health insurer. This list of important factors is not intended to be exhaustive. The health of individuals drives our focus on the environment, removing social barriers to health, and prioritizing responsible corporate governance. Managed care members jumped 1.1 million to 26.6 million. Her focus has been advancing integrated, value-based care models through the development and application of data-driven insights and technology. Centene Profile and History . The Board and I are confident that she is the right visionary leader to increase value for our shareholders and author the next chapter of Centene's growth. Centene CEO Sarah London joined CNBC 's Power Lunch with Bertha Coombs to discuss Centene's local approach as a differentiator, its data-driven strategies to enhance health outcomes, and. She soon moved to Humedica, a data analytics company. . The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. This is the Centene company profile. . Centene.com uses cookies. I have been consistently impressed by Sarah's passion to serve our members, who are often the most vulnerable amongst us. Sarah M. London is the Pres of Health Care Enterprises & Exec. She later worked for the company that produced "E.T.". Ken Fasola. Ms. London previously served as the Company's Senior Vice President of Technology Innovation and Modernization, responsible for enterprise-wide technology strategy and execution with a focus on next-generation products and services. Clayton-based Centene Corp. has appointed its vice board chair Sarah London as its new CEO. Pros. Centene Corporation 184,800 followers 5mo . This report is not for commercial use. Health insurer Centene names Sarah London as new CEO Back to video. David Westin speaks with top names in finance about the week's biggest issues on Wall Street. Of this total $0 was received as a salary, $0 was received as a bonus, $0 was received in stock options, $0 was awarded as stock and $0 came from other types of compensation. Prior to Optum Ventures, Ms. London served as Chief Product Officer for Optum Analytics, the business unit responsible for driving strategy and commercialization of Optum's integrated data and analytics solutions into the provider, payer and life sciences markets. Oregon health agency approves Amazon, One Medical acquisition, moving $3.9B deal one step forward. Ms. January 12, 2022, 8:01 AM Sarah London, Vice Chairman of Centene, joins Yahoo Finance Live to talk about Centene's health care initiatives, CMS changes, and how they are handling COVID-19. Prior to joining Humedica, Ms. London was part of the team that launched Accretive Health's Quality & Total Cost of Care business, providing end-to-end population health strategy and operational consulting to leading medical centers around the country. Cigna fell less than 0.3% to close at $234.02, giving. Over the last 19 years, insiders at Centene have traded over $220,031,916 worth of Centene stock and bought 89,005 units worth $5,026,837 Average Centene hourly pay ranges from approximately $13.23 per hour for Quality Assurance Engineer to $54.71 per hour for Senior Case Manager. Total Cash Compensationinformation is comprised of yearly Base Pay and Bonuses. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on. Ms. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in completed and future acquisitions, including statements about the impact of our recently completed acquisition of Magellan Health (the Magellan Acquisition), other recent and future acquisitions and dispositions, investments and the adequacy of our available cash resources. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission.